![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Author: Ozminkowski R.J.
Publisher: Adis International
ISSN: 1170-7690
Source: PharmacoEconomics, Vol.18, Iss.3, 2000-09, pp. : 253-264
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Inhaled anti-inflammatory drugs for asthma: better care at lower cost
Inpharma, Vol. 1, Iss. 1263, 2000-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Inhaled anti-inflammatory drugs for asthma: better care at lower cost
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 288, 2000-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Montelukast cuts use, cost of asthma/allergy medications
Inpharma, Vol. 1, Iss. 1511, 2005-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
By Koster Ellen S Raaijmakers Jan AM Koppelman Gerard H Postma Dirkje S van der Ent Cornelis K Koenderman Leo Bracke Madelon Maitland-van der Zee Anke Hilse
Pharmacogenomics, Vol. 10, Iss. 8, 2009-08 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
By Santing R.E. de Boer J. Rohof A. van der Zee N.M. Zaagsma J.
European Journal of Pharmacology, Vol. 429, Iss. 1, 2001-10 ,pp. :